Harrow's Q1 revenue and adjusted EBITDA missed expectations, exposing the need for improved revenue conversion and operating ...

Investors considering a purchase of Harrow Inc (Symbol: HROW) stock, but tentative about paying the going market price of $35.48/share, might benefit from considering selling puts among the ...

Investors considering a purchase of Harrow Inc (Symbol: HROW) shares, but tentative about paying the going market price of $32.54/share, might benefit from considering selling puts among the ...

Good morning and welcome to Harrow's Fourth Quarter and Year-End 2023 Earnings Conference Call. My name is Drew, and I will be your operator for today's call. At this time, all participants are in a ...

Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it will report its financial results for the first quarter ended March 31, ...

NYSE:DY: $25.2 million (1.9% of AUM) NYSE:AMTM: $23.1 million (1.8% of AUM) NASDAQ:ATEC: $22.8 million (1.8% of AUM) NASDAQ:MIRM: $22.6 million (1.7% of AUM) NASDAQ:WFRD: $22.3 million (1.7% of AUM) ...